This page is intended to present U.S. Securities and Exchange Commission (SEC) filings for Park Dental Partners, Inc. (NASDAQ: PARK), a dental resource organization that supports affiliated general and multi-specialty dental practices. Although no specific filings are listed in the available data here, as a Nasdaq-listed company Park Dental Partners files registration statements and other reports with the SEC in connection with its securities offerings and public company status.
In connection with its initial public offering of common stock, the company filed a registration statement that was declared effective by the SEC. The offering was conducted using a prospectus forming part of that registration statement. Investors and researchers typically look to such filings, along with annual and quarterly reports when available, to understand a company’s business model, risk factors, and capital structure.
On this SEC filings page for PARK, Stock Titan’s platform is designed to surface key regulatory documents as they become available from the SEC’s EDGAR system. These may include registration statements related to offerings, as well as periodic and current reports that describe Park Dental Partners’ operations as a dental resource organization, its relationships with affiliated practices, and other required disclosures.
AI-powered tools on the platform can help interpret lengthy filings by highlighting important sections and summarizing complex language into more accessible explanations. Users can use these features to quickly identify information related to Park Dental Partners’ business support services, its network of affiliated practices, and details connected to its public offering and any subsequent filings.
Schaefer Anna Marie reported acquisition or exercise transactions in this Form 4 filing.
Park Dental Partners, Inc. reported that director Anna Marie Schaefer received a grant of 2,632 restricted stock units (RSUs). Each RSU represents one share of common stock upon vesting. The RSUs vest in full on the first anniversary of the grant date, and were granted for no cash consideration.
Law Alan Siems reported acquisition or exercise transactions in this Form 4 filing.
Park Dental Partners, Inc. reported that director and officer Alan Siems received a grant of 7,796 restricted stock units. Each unit represents a contingent right to receive one share of common stock upon vesting. The award was granted for no cash consideration.
The restricted stock units vest in four equal installments of 25% on each of the first four anniversaries of the grant date, conditioned on Mr. Siems’ continued service and the terms of the applicable award agreement. Following this grant, he holds 7,796 restricted stock units directly.
Park Dental Partners, Inc. disclosure amends a beneficial ownership statement showing Nicholas John Swenson (via related entities AO Partners I, Park Investors LLC and AO Partners LLC) beneficially owns 295,208 shares of Common Stock, representing 6.36% of the class. The filing lists shared voting and dispositive power across the entities: 125,977, 169,231, and 125,977 shares respectively. Signatures show Mr. Swenson signed on behalf of the named entities.
Park Dental Partners, Inc. reported voting results from its 2026 annual shareholder meeting. Shareholders elected Christopher C. Smith as a Class II director to serve until the 2029 annual meeting, with 4,214,835 votes for, 586,587 withheld, and 478,173 broker non-votes.
Shareholders also ratified Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026, with 5,145,444 votes for, 1,047 against, 133,104 abstentions, and no broker non-votes. A quorum was present, with 5,279,595 of 6,608,919 eligible shares represented.
Park Dental Partners reported Q1 2026 results showing higher revenue but lower profitability. Revenue rose 6.2% to $62.7 million, driven by increased patient visits, higher reimbursement rates, and contributions from acquisitions. However, gross margin fell as salaries and benefits jumped, including $4.0 million of share-based compensation, leading to an operating loss of $1.9 million and a net loss of $0.4 million, versus a prior-year profit. Adjusted EBITDA declined 13.2% to $4.7 million, while cash flow from operations remained solid at $5.0 million. The company ended the quarter with $24.4 million in cash, $11.5 million of debt, 221 dentists across 86 locations, and significant deferred compensation obligations.
Park Dental Partners, Inc. reported first-quarter 2026 revenue of $62.7 million, up 6.2% from the prior-year period, driven by 4.1% same practice revenue growth and higher patient visits. Gross margin fell to $6.4 million and 10.2%, down from $9.9 million and 16.7%, reflecting higher salaries and benefits.
The company posted a net loss of $0.4 million, or $(0.09) per diluted share, compared with net income of $1.6 million, or $0.88 per diluted share, a year earlier. Adjusted EBITDA was $4.7 million versus $5.5 million, with margin declining to 7.6% from 9.3%.
Management reaffirmed its full-year 2026 outlook, projecting revenue of $254.0–$258.0 million and adjusted EBITDA of $21.0–$23.0 million, implying revenue growth around mid-single digits at the midpoint. The outlook assumes 3.5%–5.0% same practice revenue growth and approximately $2 million of recurring public company costs.
Park Dental Partners, Inc. is holding its first annual shareholder meeting on May 29, 2026, asking investors to elect one Class II director, Christopher C. Smith, and ratify Deloitte & Touche LLP as auditor for 2026. The company is a dental resource organization supporting affiliated practices at 86 locations with 214 dentists as of December 31, 2025. It became publicly traded on NASDAQ under ticker PARK in December 2025 and has a seven‑member staggered board, including three independent directors, with a goal to meet NASDAQ majority‑independence requirements by December 4, 2026. An innovative governance structure gives DDS Advisor LLC, representing practicing dentists who are also shareholders, the right to appoint at least three directors. As of March 30, 2026, 6,608,919 common shares are entitled to vote, including 2,093,865 unvested restricted shares. The proxy also details executive pay, equity awards with change‑in‑control vesting, related‑party subordinated notes totaling $2.165 million, and real‑estate lease arrangements with entities owned in part by certain directors.
Park Dental Partners, Inc. files its annual report describing a dentist-owned dental resource organization that provides non-clinical support to affiliated practices in Minnesota, Wisconsin and Arizona. Its affiliated network includes 214 dentists and 990 hygienists, assistants and coordinators across 86 locations.
Revenue derived from affiliated practices’ services was $244.5 million for the year ended December 31, 2025, up from $229.8 million in 2024. Most revenue is currently concentrated in Minnesota. The company emphasizes long-term administrative agreements, dentist governance rights, and a growth strategy built on acquisitions and de novo practices in medium and large U.S. metropolitan areas.
The report outlines extensive regulatory, labor and technology risks, including dependence on payor contracts, workforce shortages, complex corporate practice and fee-splitting rules, cybersecurity and HIPAA compliance. It also notes prior email-account unauthorized activity in January 2024 and discusses emerging risks tied to increasing use of artificial intelligence in dental care.
Park Dental Partners, Inc. reported higher 2025 revenue but a swing to a small annual loss and a weak fourth quarter on a GAAP basis. Full‑year revenue rose to $244.5 million from $229.8 million, with fourth‑quarter revenue up 7.5% to $61.2 million. However, gross margin narrowed and the company posted a fourth‑quarter net loss of $5.7 million and a full‑year net loss of $0.4 million, compared with net income of $4.4 million in 2024, partly reflecting higher operating and public company costs and significant share‑based compensation.
On an adjusted basis, 2025 performance was stronger. Adjusted EBITDA increased to $22.0 million from $19.4 million, and adjusted gross margin and adjusted EBITDA margin both improved, though adjusted diluted EPS declined to $2.44 from $3.17. The balance sheet strengthened meaningfully, with cash and cash equivalents rising to $25.2 million from $2.7 million and shareholders’ equity improving to $21.8 million from a deficit, helped by net proceeds of $18.4 million from the December initial public offering.
For 2026, Park Dental projects revenue between $254.0 million and $258.0 million and adjusted EBITDA of $21.0–$23.0 million, implying mid‑single‑digit revenue growth at the midpoint with roughly stable profitability. The outlook assumes 3.5%–5.0% same‑practice revenue growth, ongoing demand across services, and about $2 million of recurring public company costs.